Press releases
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
More ▼
Key statistics
On Wednesday, Edwards Lifesciences Corp (EWLS:VIE) closed at 83.61, -5.29% below its 52-week high of 88.28, set on Mar 28, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 83.29 |
---|---|
High | 83.61 |
Low | 83.29 |
Bid | 83.30 |
Offer | 83.94 |
Previous close | 83.19 |
Average volume | 0.00 |
---|---|
Shares outstanding | 602.60m |
Free float | 597.18m |
P/E (TTM) | 38.83 |
Market cap | 54.44bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 15 minutes, as of May 22 2024.
More ▼